New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...

Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio in neurology and oncology.

The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...

Philips has initiated the RADIQAL trial to assess its new ultra-low X-ray dose technology in treating coronary artery disease ...

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...

HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...